Clinical Trial Update: Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children, Adolescents and Adults (3 to 64 Years) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and immunogenicity of A/H1N1-SOIV influenza vaccine with and without adjuvant in participants aged 3 to 64 years; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Virus Infection H1n1 Subtype

Drugs mentioned

• A/H1N1-SOIV vaccine (Influenza A virus vaccine, H1N1 subtype)

Snippet

Sponsor: Novartis Vaccines | Conditions: Novel 2009 Influenza H1N1 | Phase 3 | Status: COMPLETED | Results posted: 2011-05-23